A small series of substituted cinnamic acid amides was prepared and screened for their cytotoxic activity. As a rather astonishing and unprecedented result, compound 5 holding a triisopropylsilyl (TIPS) protecting group at position 4 of the aromatic ring was highly cytotoxic (EC50 = 3.2 M for HT29 human colon adenocarcinoma cells) while analogs with a methoxy or hydroxyl group at this position were of low cytotoxicity or not cytotoxic at all.
Introduction
Cinnamic acid derivatives are widely used as flavors and fragrance 1, 2 . During the last years, compounds holding a cinnamoyl scaffold attracted attention because of their biological activities combined with low toxicity [3] [4] [5] [6] [7] [8] . However, several of these compounds have also shown cytotoxic [9] [10] [11] [12] [13] [14] as well as antimicrobial [15] [16] [17] [18] [19] [20] and anti-oxidant properties [21] [22] [23] [24] [25] [26] . Also, cinnamic acid derivatives have been used as valuable starting materials for the synthesis of peroxisome proliferatoractivated receptors (PPAR). This class of compounds is of high scientific and commercial interest for the therapy of patients suffering from diabetes mellitus type II 27, 28 .
Results and discussion
During our research on analogs of piplartine 13, 29 , we became interested in the synthesis of several amides of 4-hydroxy-3,5-dimethoxy-cinnamic acid and their biological properties, especially their cytotoxic impact on human tumor cell lines.
Reaction (Scheme 1) of syringaldehyde (1, 4hydroxy-3,5-dimethoxy-benzaldehyde) with triisopropylsilyl chloride (TIPS-Cl) gave 93% of TIPS-protected 2 30 . Its reaction with malonic acid under Knoevenagel-Doebner conditions furnished (E) configurated cinnamic acid 3. This compound is characterized in its 1 H NMR spectrum by the presence of two doublets at  = 7.61 and 6.38 ppm with a coupling constant 3 J = 15.9 Hz being typical for (E) configurated olefins. The corresponding carbons were detected in the 13 C NMR spectrum at  = 147.1 and 117.1 ppm, respectively. The reaction of piperidine with 2-chloro-ethanol gave 4 [31] [32] [33] [34] whose reaction with 3 afforded 5 as a colorless solid in 92% isolated yield. Desilylation of 5 with tetra-n-butylammonium fluoride trihydrate in THF yielded 6. Monobocylation of piperazine (7) gave mono-N-bocylated 8 35 whose reaction with 2-bromo-ethanol yielded 9. From the reaction of 9 with 3 compounds 10 was obtained. The reaction of (E) 3,4,5-trimethoxycinnamic acid (11) with 4 gave compound 12 in 90% isolated yield while its reaction with 9 afforded 13. For comparison (E) cinnamic acid 14 was transformed into esters 15 and 16, respectively.
The compounds were subjected to sulforhodamine B assays (SRB) to determine their cytotoxic activity employing several human tumor cell lines (FaDu pharynx carcinoma, A2780 ovarian carcinoma, HT29 colon adenocarcinoma, MCF-7 breast adenocarcinoma and SW1736 thyroid gland carcinoma); the results of this assays are summarized in Table 1 .
Scheme 1. Synthesis of 2-16
Reactions and conditions: a) TIPS-Cl, triethylamine, cat. DMAP, DCM, 25°C, 1 h, 93%; b) malonic acid, pyridine, cat. piperidine, 120°C, 1h, 62%; c) Cl-CH2-CH2-OH, piperidine, toluene, 70°C, 5 h, 92%; d) EDC, 4, cat. DMAP, DCM, 25°C, 1 day, 92%; e) n-Bu4NF trihydrate, THF, 25°C, 6 h, 87%; f) according to lit. 35 Interestingly, most of the cytotoxicity is lost for desilylated 6. The reason for this loss of cytotoxicity cannot be explained by the mere presence of a free phenolic hydroxy group in compound 6. Compounds 12 (with a methoxy group on the phenyl substituent) and 15 (only hydrogen substituents on the ring) have no cytotoxicity either. Thus, the reason for the enhanced cytotoxicity of 5 remains unclear and will be subject to further studies concerning also the modeof-action for this class of compounds.
Conclusion
Several cinnamic acid derived amides were prepared and screened for their cytotoxic activity employing five human tumor cell lines. Interestingly, a piperidinyl-ethyl substituted 3,5-dimethoxy cinnamic acid amide 5 carrying a TIPS protecting group at position 4 was highly cytotoxic for all tumor cell lines in the low M concentration range. While analogs holding a hydroxyl group (as exemplified in 6) or a methoxy substituent (as exemplified in 12) or no substituents (as exemplified in 15) at this position were of significantly reduced cytotoxicity or were not cytotoxic at all.
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Experimental
Melting points are uncorrected (Leica hot stage microscope), NMR spectra were recorded using the Varian spectrometer Gemini 2000 (δ given in ppm, J in Hz), MS spectra were taken on a Finnigan MAT LCQ 7000 (electrospray, voltage 4.5 kV, sheath gas nitrogen) instrument. TLC was performed on silica gel (Merck 5554); elemental analyses were performed on a Vario EL (CHNS). The solvents were dried according to usual procedures (DCM by distillation over K2CO3, pyridine over KOH, toluene over Na). The purity of the compounds was determined by HPLC and found to be > 97%.
Sulforhodamine B assay (SRB)
The cytotoxicity of the compounds was evaluated using the sulforhodamine-B (Kiton-Red S, ABCR) micro culture colorimetric assay. Cells were seeded into 96-well plates on day 0 at appropriate cell densities to prevent confluence of the cells during the period of the experiment. After 24 hours, the cells were treated with six different concentrations (1, 3, 7, 12, 20 and 30 µM) minimum. The final concentration of DMSO/DMF never exceeded 0.5%, which was non-toxic to the cells. After a 96 h treatment, the supernatant medium from the 96-well plates was discarded, the cells were fixed with 10% trichloroacetic acid (TCA) and allowed to rest at 4°C. After 24 h fixation, the cells were washed in a strip washer and dyed with SRB solution (100 µL, 0.4% in 1 % acetic acid) for about 20 min. After dying, the plates were washed four times with 1% acetic acid to remove the excess of the dye and allowed to air-dry overnight. Tris base solution (200 µL, 10 mM) was added to each well and absorbance was measured at λ = 570 nm using a 96 well plate reader (Tecan Spectra, Crailsheim, Germany). The EC50 values were averaged from three independent experiments performed each in triplicate calculated from semilogarithmic dose-response curves applying a nonlinear 4P Hills-slope equation (GraphPad Prism5; variables top and bottom were set to 100 and 0, respectively).
3,5-Dimethoxy-4-[(triisopropyl)silyloxy]benzaldehyde (2)
To a solution of 4-hydroxy-3,5-dimethoxybenzaldehyde (1, 9. 
(E) 2-(Piperidin-1-yl)-ethyl 3-[3,5-dimethoxy-4-[(triisopropylsilyl)oxy]phenyl]-acrylate (5)
Following the procedure given for the preparation of 15, from 3 (2.69 g, 7.07 mmol) and 4 (1.29 g, 9.98 mmol), 5 ( 
Piperazine (7)
This compound was commercially obtained from Merck and used as received.
N-Boc-piperazine (8)
This compound was prepared from 7 in 71% yield according to literature; m.p. 46-48°C (lit.: 35 
(E) tert-Butyl 4-[2-[(3-(3,5-dimethoxy-4-(triisopropylsilyl)oxy)phenyl]acryloyl)oxy)ethyl)piperazine-1-carboxylate (10)
Following the procedure given for the preparation of 15, from 3 (1.0 g, 2.95 mmol) and 9 (0.908 g, 3.94 mmol) 10 (1.28 g, 73%) was obtained as a colorless solid; m. 
(E) Cinnamic acid (14)
(E) 2-(Piperidin-1-yl)-ethyl cinnamate (15)
To a solution of cinnamic acid (14, 2.0 g, 13.5 mmol) in dry DCM (40 mL) 4 (2.6 g, 20.12 mmol) and EDC (3.14 g, 20.23 mmol) and cat. amounts of DMAP were added, and the mixture was stirred for 1 day at room temperature. Usual aqueous workup followed by column chromatography (silica gel, hexane/ethyl acetate/triethylamine, 100:50: 
(E) tert-Butyl 4-[2-(cinnamoyloxy)ethyl]piperazine-1-carboxylate (16)
Following the procedure given for the preparation of 15, from 14 (200 mg, 1.35 mmol) and 9 (466 mg, 2.02 mmol), 16 (301 mg, 62%) was obtained as a colorless oil; b.p. 153°C (1 bar); RF = 0.25 (hexane/ethyl acetate/triethylamine, 100:50:3);
